Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Authors
Keywords
-
Journal
Journal of Ophthalmology
Volume 2011, Issue -, Pages 1-6
Publisher
Hindawi Limited
Online
2011-06-13
DOI
10.1155/2011/742020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravitreal Ranibizumab for Choroidal Neovascularization in Angioid Streaks
- (2010) Gerard Mimoun et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Improvement of Angiographic Findings of Polypoidal Choroidal Vasculopathy After Intravitreal Injection of Ranibizumab Monthly for 3 Months
- (2010) Taiichi Hikichi et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Polypoidal Choroidal Vasculopathy Masquerading as Neovascular Age-Related Macular Degeneration Refractory to Ranibizumab
- (2010) Alexandros N. Stangos et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab
- (2010) Akitaka Tsujikawa et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients
- (2010) Mihoko Suzuki et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological Myopia
- (2010) Angela M. Carneiro et al. OPHTHALMOLOGICA
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results
- (2009) G. T Kokame et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: A 30-month multicenter study in Hyogo, Japan
- (2009) Shigeru Honda et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- INTRAVITREAL RANIBIZUMAB FOR THE PRIMARY TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA
- (2009) TIMOTHY Y. Y. LAI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Ranibizumab for neovascular age-related macular degeneration
- (2008) L. J. Hernandez-Pastor et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy
- (2008) T Y Y Lai et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization
- (2008) Lazaros Konstantinidis et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration
- (2008) Michael S. Ip et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients
- (2007) Fumi Gomi et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More